文献速递肺栓塞与肺血管病呼吸道感染

COVID-19感染中肺栓塞:高病死率与肺栓塞特征相关

Pulmonary embolism in COVID-19 infection: a high case-fatality related to pulmonary embolism characteristics.
PubMed 文献 · Eur Respir J · 2023-01-27

在COVID-19患者中,肺栓塞(PE)与非COVID-19的PE患者及无PE的COVID-19患者相比预后更差,强调需要专门充分的血栓预防和诊断策略。SARS-CoV-2感染最初被认为是主要临床表现,与严重肺实质损伤相关,似乎是疾病严重程度和死亡率的主要原因。大流行开始数月后,证据表明COVID-19感染与静脉血栓栓塞(VTE)风险增加相关,尤其是PE和原位肺动脉血栓形成。

要点

  • COVID-19合并PE患者预后差于非COVID-19的PE患者。
  • COVID-19合并PE患者预后也差于无PE的COVID-19患者。
  • 需专门充分的血栓预防和诊断策略。

核心结论

  • COVID-19患者中PE与更差预后相关,强调需要专门充分的血栓预防和诊断策略。

主要发现

  • COVID-19患者中PE与非COVID-19的PE患者及无PE的COVID-19患者相比预后更差。
  • COVID-19感染与静脉血栓栓塞风险增加相关,尤其是PE和原位肺动脉血栓形成。

临床怎么用

  • 对COVID-19患者应考虑充分的血栓预防和诊断策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary embolism (PE) in COVID-19 patients is associated with poorer outcomes than in non-COVID-19 patients with PE, and in COVID-19 patients without PE, emphasising the need for dedicated adequate thromboprophylactic and diagnostic strategies https://bit.ly/3QrQy7t The devastating outbreak of 2019 novel coronavirus disease (COVID-19) has markedly weakened healthcare systems throughout the world [1, 2]. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was the first recognised main clinical presentation, which is associated with severe lung parenchymal damage, and this syndrome appeared to be the main cause of disease severity and mortality [1]. However, a few months after the pandemic started, evidence indicated that COVID-19 infection was associated with an increased risk of venous thromboembolism (VTE), and particularly pulmonary embolism (PE) and in situ pulmonary thrombosis [3].

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Couturaud, Tromeur, Le Mao, et al. Pulmonary embolism in COVID-19 infection: a high case-fatality related to pulmonary embolism characteristics. Eur Respir J. 2023. PMID: 36707229. doi:10.1183/13993003.02447-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。